Retatrutide (Reta) 10 mg

Retatrutide, commonly known as Reta, is a research peptide currently being studied for its effects on appetite, metabolism, blood sugar regulation and body weight.

Unlike peptides that focus on a single pathway, Retatrutide works across three different receptors — GLP-1, GIP and glucagon. Researchers are studying how targeting all three pathways may influence hunger, food intake and the way the body uses and stores energy.

Product Details

• Retatrutide (LY3437943)

• 10 mg per vial

• Freeze-dried (lyophilised) powder

• Triple GLP-1, GIP & glucagon receptor agonist

• Supplied for laboratory research

The 10 mg refers to the total amount of Retatrutide contained in the vial and is not a dosing recommendation.

For research purposes only. Not intended for human or veterinary use.